These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10578819)

  • 21. CDC VRE guidelines still relevant.
    Hosp Peer Rev; 1998 Feb; 23(2):25-7. PubMed ID: 10178213
    [No Abstract]   [Full Text] [Related]  

  • 22. [What is to be done with vancomycin-resistant enterococcal infections?].
    Bonten MJ; Mascini EM; Willems R; Timmer GJ; Gaillard CA; Vandenbroucke-Grauls CM
    Ned Tijdschr Geneeskd; 2000 Dec; 144(53):2545-9. PubMed ID: 11191789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Control of endemic vancomycin-resistant Enterococcus among inpatients at a university hospital.
    Calfee DP; Giannetta ET; Durbin LJ; Germanson TP; Farr BM
    Clin Infect Dis; 2003 Aug; 37(3):326-32. PubMed ID: 12884155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Vancomycin resistant Enterococci (VRE)].
    Lesens O
    Nephrol Ther; 2009 Jun; 5 Suppl 4():S261-4. PubMed ID: 19596346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implications of colonization of vancomycin-resistant enterococci (VRE) in renal dialysis patients. Learning to live with it?
    Humphreys H; Dolan V; Sexton T; Conlon P; Rajan L; Creamer E; Walshe J; Donohoe J; Smyth EG
    J Hosp Infect; 2004 Sep; 58(1):28-33. PubMed ID: 15350710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The leader's role in stopping the bugs.
    Schaffner M; Johnson J
    Gastroenterol Nurs; 2001; 24(5):264-5. PubMed ID: 11847999
    [No Abstract]   [Full Text] [Related]  

  • 27. New and emerging pathogens. Part 5. Those crazy cocci: more virulent and resistant to antibiotics than ever.
    Paul S; Pilot KE; Dalley E; Brown JW
    MLO Med Lab Obs; 1996 Jun; 28(6):40-2, 44, 46 passim. PubMed ID: 10172683
    [No Abstract]   [Full Text] [Related]  

  • 28. MRSA, VRE, and VRSA: how do we control them in nursing homes?
    Goldrick BA
    Am J Nurs; 2004 Aug; 104(8):50-1. PubMed ID: 15300047
    [No Abstract]   [Full Text] [Related]  

  • 29. Report from the Catalan Agency for Health Technology Assessment (CAHTA). Review of the scientific evidence of the clinical and economic implications of resistance of enterococcus to vancomycin.
    Int J Technol Assess Health Care; 1999; 15(4):767-9. PubMed ID: 10645118
    [No Abstract]   [Full Text] [Related]  

  • 30. Update on emerging infections: news from the Centers for Disease Control and Prevention.
    Moran GJ; Mount J
    Ann Emerg Med; 2003 Jan; 41(1):148-51. PubMed ID: 12514697
    [No Abstract]   [Full Text] [Related]  

  • 31. Draft guideline published on preventing the spread of VRE infections. Hospital Infection Control Practices Advisory Committee.
    Lancaster AD
    Asepsis; 1994; 16(3):19-22. PubMed ID: 7880496
    [No Abstract]   [Full Text] [Related]  

  • 32. Insights into the epidemiology and control of infection with vancomycin-resistant enterococci.
    Hayden MK
    Clin Infect Dis; 2000 Oct; 31(4):1058-65. PubMed ID: 11049790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The burden of vancomycin-resistant enterococcal infections in US hospitals, 2003 to 2004.
    Reik R; Tenover FC; Klein E; McDonald LC
    Diagn Microbiol Infect Dis; 2008 Sep; 62(1):81-5. PubMed ID: 18508225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid control of an outbreak of vancomycin-resistant enterococci in a French university hospital.
    Lucet JC; Armand-Lefevre L; Laurichesse JJ; Macrez A; Papy E; Ruimy R; Deblangy C; Lozach A; Lolom I; Jarlier V; Andremont A; Leport C
    J Hosp Infect; 2007 Sep; 67(1):42-8. PubMed ID: 17719129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical correlates of vancomycin-resistant enterococci/meticillin-resistant Staphylococcus aureus co-colonization and co-infection in Singapore.
    Kurup A; Wong YY; Tan KY; Low JG
    J Hosp Infect; 2008 Nov; 70(3):291-2. PubMed ID: 18804897
    [No Abstract]   [Full Text] [Related]  

  • 36. System-wide surveillance for clinical encounters by patients previously identified with MRSA and VRE.
    Evans RS; Lloyd JF; Abouzelof RH; Taylor CW; Anderson VR; Samore MH
    Stud Health Technol Inform; 2004; 107(Pt 1):212-6. PubMed ID: 15360805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of vancomycin-resistant enterococci colonization and its risk factors in chronic hemodialysis patients in Shiraz, Iran.
    Assadian O; Askarian M; Stadler M; Shaghaghian S
    BMC Infect Dis; 2007 Jun; 7():52. PubMed ID: 17553129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of a successful vancomycin-resistant Enterococcus prevention intervention in a community of health care facilities.
    Sohn AH; Ostrowsky BE; Sinkowitz-Cochran RL; Quirk SB; Jarvis WR
    Am J Infect Control; 2001 Feb; 29(1):53-7. PubMed ID: 11172319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outbreak of vancomycin-resistant Enterococcus spp. in an Italian general intensive care unit.
    Peta M; Carretto E; Barbarini D; Zamperoni A; Carnevale L; Perversi L; Pagani M; Bonora MG; Fontana R; Marone P; Langer M
    Clin Microbiol Infect; 2006 Feb; 12(2):163-9. PubMed ID: 16441455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rate of nosocomial transmission of vancomycin-resistant enterococci from isolated patients.
    Cheng AC; Harrington G; Russo P; Liolios L; Spelman D
    Intern Med J; 2004 Aug; 34(8):510-2. PubMed ID: 15317552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.